Onclive articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Sat, 25 Oct 2014 14:13:34 EDT 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Novel Drugs Are Being Studied in GU Cancers]]>http://www.onclive.com/publications/urologists-in-cancer-care/2014/October-2014/Novel-Drugs-Are-Being-Studied-in-GU-CancersOnclive articlesusSat, 25 Oct 2014 08:01:01 EDTOnclive<![CDATA[ICD-10 and Urologic Oncology: A Disappointing Combination]]>http://www.onclive.com/publications/urologists-in-cancer-care/2014/October-2014/ICD-10-and-Urologic-Oncology-A-Disappointing-CombinationOnclive articlesusFri, 24 Oct 2014 15:01:01 EDTOnclive<![CDATA[Big Promise From Big Data]]>http://www.onclive.com/publications/oncology-business-news/2014/October-2014/Big-Promise-From-Big-DataOnclive articlesusFri, 24 Oct 2014 09:45:29 EDTOnclive<![CDATA[Z-Code Identifiers Give Providers Objective Information About Molecular Tests]]>http://www.onclive.com/publications/oncology-business-news/2014/October-2014/Z-Code-Identifiers-Give-Providers-Objective-Information-About-Molecular-TestsOnclive articlesusThu, 23 Oct 2014 15:01:01 EDTOnclive<![CDATA[Game Changers in Prostate Cancer]]>http://www.onclive.com/publications/urologists-in-cancer-care/2014/October-2014/Game-ChangersOnclive articlesusThu, 23 Oct 2014 09:03:29 EDTOnclive<![CDATA[Approval Sought for Ibrutinib in Waldenström's Macroglobulinemia]]>http://www.onclive.com/web-exclusives/SNDA-Submitted-for-Ibrutinib-in-Waldenstrms-MacroglobulinemiaOnclive articlesusWed, 22 Oct 2014 16:16:52 EDTOnclive<![CDATA[Expert Says pCR Data Support Neoadjuvant Therapy in HER2-Positive Breast Cancer]]>http://www.onclive.com/publications/Oncology-live/2014/November-2014/Expert-Says-pCR-Data-Support-Neoadjuvant-Therapy-in-HER2-Positive-Breast-CancerOnclive articlesusWed, 22 Oct 2014 09:04:55 EDTOnclive<![CDATA[European Commission Approves Ibrutinib for MCL, CLL]]>http://www.onclive.com/web-exclusives/European-Commission-Approves-Ibrutinib-for-MCL-CLLOnclive articlesusTue, 21 Oct 2014 18:44:13 EDTOnclive<![CDATA[How Test Reimbursement Decisions Are Made: A Leader of Medicare’s MolDX Program Discusses Evaluation Process]]>http://www.onclive.com/publications/urologists-in-cancer-care/2014/October-2014/How-Test-Reimbursement-Decisions-Are-Made-A-Leader-of-Medicares-MolDX-Program-Discusses-Evaluation-ProcessOnclive articlesusTue, 21 Oct 2014 16:03:12 EDTOnclive<![CDATA[The Promise of Big Data Gets Closer to Fulfillment]]>http://www.onclive.com/publications/oncology-business-news/2014/October-2014/The-Promise-of-Big-Data-Gets-Closer-to-FulfillmentOnclive articlesusTue, 21 Oct 2014 10:13:44 EDTOnclive